Developer docs
API playgroundTry for free, no card

Search company profiles

PhantomX

Full company profile

uuid000i4dh

Namestring
PhantomX
Legal namestring
PhantomX GmbH
Websiteurl
phantomx.de
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging phantoms, anthropomorphic CT phantoms, AI validation tools, radiology training models, diagnostic imaging simulation
Industry3 codes
PRIMARYIMAAAFAI
Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
Industrials, Manufacturing & Construction/3D Printing/Rapid Prototyping & Product Development (Additive)
SECONDARYIMAAADAN
Inspection, Metrology & Certification Services for Additive Parts
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAAAHAC
Metrology & Inspection Systems (CMM, Laser Trackers, Optical Comparators)
Industrials, Manufacturing & Construction/3D Printing/3D Scanning & Metrology for Additive Manufacturing
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Plastics Product Manufacturing3261
SIC code2 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Medical Imaging Phantoms
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Imaging Phantoms
TypeHardware Sales
Description

Sale of highly realistic anthropomorphic phantoms for clinical imaging and AI validation. Products include head, abdomen, torso, breast, child, and extremity phantoms with various pathologies and diagnostic features. Also includes accessory products such as fat rings and calcification patterns.

phantomx.de
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Marketing or Sales, Operations, Personnel
Pricing details1 tier
1Custom Quote-Based Pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products are priced through custom quotes rather than public catalog pricing. The company website features a 'Request a Quote' system where customers can add products to a list and submit quote requests.

phantomx.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PhantomX manufactures highly realistic anthropomorphic medical imaging phantoms constructed from cellulose-polymer composite materials and based on real patient DICOM data. The phantoms simulate human anatomy and pathology for use in clinical imaging validation, AI software testing and benchmarking, and training of medical imaging professionals without patient exposure. The company also offers custom patient-specific phantom manufacturing services from CT data, AI validation solutions, and AI development data generation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Unlimited scanning under reproducible conditions
+1 more record
Product overview1 text field

PhantomX is a manufacturer of highly realistic medical imaging phantoms for clinical imaging validation and AI development. The product portfolio centers on anthropomorphic CT phantoms including head/brain, abdomen, pelvis, torso, breast, child, and extremities phantoms with disease-specific variants (aneurysms, strokes, liver lesions, fractures, calcifications). The portfolio also includes AI validation services using phantoms to test AI software output, and AI development data services providing controlled scan datasets for training AI applications. Add-on accessories include fat rings and calcification patterns. Custom manufacturing services create patient-specific phantoms from CT data. The company was acquired by IBA in November 2025 to integrate AI quality assurance into IBA's dosimetry solutions.

Product and service12 records
1Head Phantoms
CategoryMedical Imaging Phantoms
Description

CT phantoms simulating contrast-enhanced head in arterial phase (CTA) for stroke, bleed, aneurysm, and AVM detection, covering vertex to foramen magnum with realistic vascular structures. Designed for medical imaging validation and AI training.

2Abdomen Phantoms
CategoryMedical Imaging Phantoms
Description

CT phantoms simulating contrast-enhanced abdomen in arterial, portal venous phases, or native, with variants for liver lesions, cirrhosis, aortic aneurysm, and liver metastases, covering T10-L4 vertebrae. Targeted at diagnostic imaging validation.

3Abdomen/Pelvis Phantoms
CategoryMedical Imaging Phantoms
Description

CT phantoms covering lumbar spine to perineum with portal venous phase or native contrast, featuring pancreatic masses and liver lesions for diagnostic validation.

4Torso Phantoms
CategoryMedical Imaging Phantoms
Description

Full thorax-to-perineum phantoms in portal venous phase with vasculature, bone and soft tissues including heart, liver, kidneys, and prostate for comprehensive body imaging validation.

5Child Torso Phantoms
CategoryMedical Imaging Phantoms
Description

Pediatric phantoms simulating 1-year-old and 3-year-old children with contrast-enhanced thorax, abdomen and pelvis in portal venous phase for age-specific imaging validation.

6Breast Phantoms
CategoryMedical Imaging Phantoms
Description

Mammography phantoms simulating compressed breast with four slabs, insertable calcification patterns, and replaceable tumor slabs for breast cancer AI simulation applications.

7Extremities Phantoms
CategoryMedical Imaging Phantoms
Description

Hand and foot phantoms simulating bone fractures (metacarpal, metatarsal) for radiography and CT validation of bone fracture detection AI.

8Pelvis Phantoms
CategoryMedical Imaging Phantoms
Description

Pelvis phantoms without contrast covering L5 to perineum, featuring femoral neck fractures for bone fracture detection and body composition analysis.

9Uniform Abdomen Phantoms
CategoryMedical Imaging Phantoms
Description

Semianthropomorphic phantoms with fixed organ contours and 64 spherical liver lesions for standardized low-contrast detectability testing.

10AI Validation Solutions
CategoryAI Validation Services
Description

End-to-end AI software validation services using anatomical phantoms for reproducibility testing, diagnostic performance evaluation, and benchmarking of AI networks under varying imaging conditions.

11AI Development Data
CategoryAI Validation Services
Description

Phantom scan data services providing controlled anatomical, pathological, dose, and reconstruction parameters for training and developing AI applications in clinical imaging.

12Custom Phantom Manufacturing
CategoryCustom Manufacturing Services
Description

Patient- and disease-specific anthropomorphic phantom manufacturing from CT data, plus customization services for adapting standard phantoms to specific requirements.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
1IBA (Ion Beam Applications)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-11-03
Description

IBA, a leading provider of particle accelerator technology, acquired PhantomX GmbH in November 2025. The acquisition integrates AI Quality Assurance into IBA's dosimetry solutions. PhantomX now operates as IBA PhantomX, strengthening IBA's healthcare diagnostics and therapeutic systems portfolio with AI-based medical solutions. The move aims to accelerate innovation and expand market reach in AI-driven medical solutions.

globenewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PhantomX emerged from research at Charité University Hospital in Berlin and maintains a strong ongoing partnership. Current collaboration includes development and validation of a novel hydrogel-based 3D printing system to produce realistic MRI phantoms. The project is co-funded by the European Union and advances MR imaging validation and diagnostic applications including radiomics and AI.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PhantomX

Medical Imaging Phantomsphantomx.de

PhantomX firmographics

Firmographics
Name
PhantomX
Legal name
PhantomX GmbH
Website
https://phantomx.de
Company type
Private
Operating status
Acquired
Headcount range
1–10 employees
Ownership category
akta.pro rank

PhantomX industry classification

Industry
Product category
Medical Imaging Phantoms
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Plastics Product Manufacturing (3261)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYIMAAAFAI
Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
Industrials, Manufacturing & Construction/3D Printing/Rapid Prototyping & Product Development (Additive)
SECONDARYIMAAADAN
Inspection, Metrology & Certification Services for Additive Parts
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAAAHAC
Metrology & Inspection Systems (CMM, Laser Trackers, Optical Comparators)
Industrials, Manufacturing & Construction/3D Printing/3D Scanning & Metrology for Additive Manufacturing

Keywords

  • Medical imaging phantoms
  • Anthropomorphic CT phantoms
  • AI validation tools
  • Radiology training models
  • Diagnostic imaging simulation

Where PhantomX is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

PhantomX business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Marketing or Sales, Operations, Personnel

Revenue model

  1. Medical Imaging Phantoms: Sale of highly realistic anthropomorphic phantoms for clinical imaging and AI validation. Products include head, abdomen, torso, breast, child, and extremity phantoms with various pathologies and diagnostic features. Also includes accessory products such as fat rings and calcification patterns.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCustom Quote-Based Pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

PhantomX product offering

Product offering

Core offering

PhantomX manufactures highly realistic anthropomorphic medical imaging phantoms constructed from cellulose-polymer composite materials and based on real patient DICOM data. The phantoms simulate human anatomy and pathology for use in clinical imaging validation, AI software testing and benchmarking, and training of medical imaging professionals without patient exposure. The company also offers custom patient-specific phantom manufacturing services from CT data, AI validation solutions, and AI development data generation.

Product overview

PhantomX is a manufacturer of highly realistic medical imaging phantoms for clinical imaging validation and AI development. The product portfolio centers on anthropomorphic CT phantoms including head/brain, abdomen, pelvis, torso, breast, child, and extremities phantoms with disease-specific variants (aneurysms, strokes, liver lesions, fractures, calcifications). The portfolio also includes AI validation services using phantoms to test AI software output, and AI development data services providing controlled scan datasets for training AI applications. Add-on accessories include fat rings and calcification patterns. Custom manufacturing services create patient-specific phantoms from CT data. The company was acquired by IBA in November 2025 to integrate AI quality assurance into IBA's dosimetry solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Head Phantoms CT phantoms simulating contrast-enhanced head in arterial phase (CTA) for stroke, bleed, aneurysm, and AVM detection, covering vertex to foramen magnum with realistic vascular structures. Designed for medical imaging validation and AI training.
  • Abdomen Phantoms CT phantoms simulating contrast-enhanced abdomen in arterial, portal venous phases, or native, with variants for liver lesions, cirrhosis, aortic aneurysm, and liver metastases, covering T10-L4 vertebrae. Targeted at diagnostic imaging validation.
  • Abdomen/Pelvis Phantoms CT phantoms covering lumbar spine to perineum with portal venous phase or native contrast, featuring pancreatic masses and liver lesions for diagnostic validation.
  • Torso Phantoms Full thorax-to-perineum phantoms in portal venous phase with vasculature, bone and soft tissues including heart, liver, kidneys, and prostate for comprehensive body imaging validation.
  • Child Torso Phantoms Pediatric phantoms simulating 1-year-old and 3-year-old children with contrast-enhanced thorax, abdomen and pelvis in portal venous phase for age-specific imaging validation.
  • Breast Phantoms Mammography phantoms simulating compressed breast with four slabs, insertable calcification patterns, and replaceable tumor slabs for breast cancer AI simulation applications.
  • Extremities Phantoms Hand and foot phantoms simulating bone fractures (metacarpal, metatarsal) for radiography and CT validation of bone fracture detection AI.
  • Pelvis Phantoms Pelvis phantoms without contrast covering L5 to perineum, featuring femoral neck fractures for bone fracture detection and body composition analysis.
  • Uniform Abdomen Phantoms Semianthropomorphic phantoms with fixed organ contours and 64 spherical liver lesions for standardized low-contrast detectability testing.
  • AI Validation Solutions End-to-end AI software validation services using anatomical phantoms for reproducibility testing, diagnostic performance evaluation, and benchmarking of AI networks under varying imaging conditions.
  • AI Development Data Phantom scan data services providing controlled anatomical, pathological, dose, and reconstruction parameters for training and developing AI applications in clinical imaging.
  • Custom Phantom Manufacturing Patient- and disease-specific anthropomorphic phantom manufacturing from CT data, plus customization services for adapting standard phantoms to specific requirements.

Quantifiable outcome

  • Unlimited scanning under reproducible conditions
  • +1 more outcomes

Companies that use PhantomX

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

PhantomX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

PhantomX partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • IBA (Ion Beam Applications)flagshipStrategic or Co-development Partner · 3 November 2025IBA, a leading provider of particle accelerator technology, acquired PhantomX GmbH in November 2025. The acquisition integrates AI Quality Assurance into IBA's dosimetry solutions. PhantomX now operates as IBA PhantomX, strengthening IBA's healthcare diagnostics and therapeutic systems portfolio with AI-based medical solutions. The move aims to accelerate innovation and expand market reach in AI-driven medical solutions.
  • Charité Universitätsmedizin BerlincoreStrategic or Co-development PartnerPhantomX emerged from research at Charité University Hospital in Berlin and maintains a strong ongoing partnership. Current collaboration includes development and validation of a novel hydrogel-based 3D printing system to produce realistic MRI phantoms. The project is co-funded by the European Union and advances MR imaging validation and diagnostic applications including radiomics and AI.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

PhantomX competitors and assessment

Company assessment

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

PhantomX social profiles

Digital presence

PhantomX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PhantomX leadership team

Management profile

Number of profiles

Profiles3 records

PhantomX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PhantomX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PhantomX

What does PhantomX do?

PhantomX manufactures highly realistic anthropomorphic medical imaging phantoms constructed from cellulose-polymer composite materials and based on real patient DICOM data. The phantoms simulate human anatomy and pathology for use in clinical imaging validation, AI software testing and benchmarking, and training of medical imaging professionals without patient exposure. The company also offers custom patient-specific phantom manufacturing services from CT data, AI validation solutions, and AI development data generation.

Is PhantomX a public or private company?

PhantomX is a private company. It is classified as corporate owned and is currently acquired.

When was PhantomX founded?

PhantomX was founded in -1. It employs 1 to 10 people.

Where is PhantomX based?

PhantomX is headquartered in Berlin, Germany, in the Europe region.

How does PhantomX make money?

One revenue line is on record: medical Imaging Phantoms.

Does PhantomX have an API?

No public API is recorded for PhantomX.

What industry is PhantomX in?

PhantomX's product category is Medical Imaging Phantoms. Its primary akta.pro industry code is IMAAAFAI, Medical & Dental Prototyping (Models, Guides, Pre-Op Planning), with a secondary code of IMAAADAN, Inspection, Metrology & Certification Services for Additive Parts. Its NAICS code is 325413 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceThird quarter 2025 update: IBA is highly confident to meet FY2025 guidance, and strengthens financing structureIBA (Ion Beam Applications SA) reported Q3 2025 business results with equipment order intake of €195 million (+6% YoY), confirmed FY2025 REBIT guidance of at least €25 million, and closed a €125 million refinancing club deal with Belgian and international banks. The company has €1.3 billion backlog stable and completed the acquisition of Berlin-based PhantomX, while its PanTera joint venture broke ground on a commercial-scale Ac-225 production facility. IBA reiterated mid-term outlook of 5-7% revenue CAGR and ~10% REBIT margin by 2028, while monitoring geopolitical risks including US tariffs and Chinese market restrictions.BioSpaceIBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbHIBA (Ion Beam Applications S.A.) has announced the acquisition of PhantomX GmbH, expanding its portfolio in healthcare diagnostics and therapeutic systems with AI quality assurance capabilities. PhantomX, founded in 2018 and supported by Charité University Hospital in Berlin, is a recognized leader in realistic anthropomorphic phantoms used globally for validating diagnostic and therapeutic imaging systems, including AI applications in medical imaging. The acquisition is expected to accelerate innovation in IBA's Medical Imaging Business Line with simulation and AI-driven technologies, according to Jean-Marc Bothy, President of IBA Dosimetry.PhantomxIBA acquires PhantomX GmbHIBA (Ion Beam Applications S.A.), the Belgian world leader in particle accelerator technology and quality assurance solutions, has acquired PhantomX GmbH to integrate artificial intelligence quality assurance into its dosimetry portfolio. PhantomX, founded in 2018 with support from Charité University Hospital in Berlin, specializes in realistic anthropomorphic phantoms used globally for validating diagnostic and therapeutic imaging systems and is recognized for AI validation in medical imaging. The acquisition is expected to accelerate innovation in IBA's Medical Imaging Business Line with simulation and AI-driven technologies.Iba-WorldwideIBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbHIBA (Ion Beam Applications S.A.) has acquired PhantomX GmbH, a company specializing in realistic anthropomorphic phantoms for validating diagnostic and therapeutic imaging systems. The acquisition strengthens IBA's dosimetry portfolio by adding PhantomX's expertise in AI quality assurance for medical imaging applications. Together, the companies aim to accelerate innovation in medical imaging with simulation and AI-driven technologies, delivering greater value to clinicians and patients worldwide.GlobeNewswireIBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbHIBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and quality assurance solutions, announced on November 3, 2025, the acquisition of PhantomX GmbH, a German company founded in 2018 that develops realistic anthropomorphic phantoms used for validating AI-enabled medical imaging and therapeutic systems. The acquisition strengthens IBA's dosimetry portfolio and healthcare diagnostics capabilities with AI validation technologies, with PhantomX's expertise described as complementing IBA's existing Clinical Workflow Solutions in Radiation Therapy and Medical Imaging. The companies expect the combination to accelerate innovation in medical imaging using simulation and AI-driven technologies.